Patent · US Active

Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)

US9157918B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

PROBIODRUG AG · DE

Inventors

Holger Cynis · Dohnsen, DE
Hans-Ulrich Demuth · Halle (Saale), DE
Jens-Ulrich Rahfeld · Lieskau, DE
Stephan Schilling · Halle (Saale), DE
Kathrin Gans · Halle (Saale), DE
Sonja Kampfer · Germering, DE

Key dates

Filing date	Jul 23, 2013
Grant date	Oct 13, 2015
Priority date	—
Expiry date	Jul 23, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Monoclonal antibodies which bind specifically to the proinflammatory cytokine pyroglutamate MCP-1 (MCP-1 N1pE).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.